查找临床试验
已按「肝癌」检索，对应国际通用词 hepatocellular carcinoma
共找到 12 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 09:59，每 5 分钟自动同步The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine
China
年龄 18 Years – 70 Years
Anhui Provincial Hospital
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
United States、China、Israel、Japan、Puerto Rico 等 7 国
年龄 18 Years – 不限
AbbVie
CT011 Autologous CAR-T Cells in Patients With Hepatocellular Carcinoma at Risk of Recurrence After Surgical Resection
China
年龄 18 Years – 75 Years
CARsgen Therapeutics Co., Ltd.
A Study of AK112, a PD-1/ VEGF Bispecific Antibody, for Resectable Hepatocellular Carcinoma With High Recurrence Risk
China
年龄 18 Years – 75 Years
The First Affiliated Hospital of Zhengzhou University
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
United States、Japan、Puerto Rico、Taiwan
年龄 18 Years – 不限
Pfizer
The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities
China
年龄 18 Years – 80 Years
First Affiliated Hospital of Wenzhou Medical University
A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer
United States、Belgium、Canada、China、Finland 等 9 国
年龄 18 Years – 不限
Bayer
Immunotherapy for Hepatocellular Carcinoma
China
年龄 18 Years – 不限
The First Affiliated Hospital with Nanjing Medical University
Trametinib Combined With Everolimus and Lenvatinib for Recurrent/Refractory Advanced Solid Tumors
China
年龄 18 Years – 85 Years
Second Affiliated Hospital of Guangzhou Medical University
Lenvatinib Plus DEB-TACE and HAIC vs. Lenvatinib Plus DEB-TACE for Large HCC With PVTT
China
年龄 18 Years – 75 Years
Second Affiliated Hospital of Guangzhou Medical University
Hyperpolarized 13C-MRI in Patients With Hepatocellular Carcinoma Undergoing Radiotherapy, Atezolizumab, and Bevacizumab
Taiwan
年龄 18 Years – 不限
Chang Gung Memorial Hospital
TACE Combined With Lenvatinib and PD-1 Inhibitor for Ruptured Hepatocellular Carcinoma
China
年龄 18 Years – 75 Years
Sun Yat-sen University